#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	1854	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2412	153.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1522	1522	C	210	C	132	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	1854	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2412	153.6	0	HET	.	.	.	G1447A	.	1447	1447	G	1785	1785	G	226	G,A	107,33	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	1854	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2412	153.6	0	HET	.	.	.	A69G	.	69	69	A	407	407	A	194	A,G	87,39	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3340	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3815	168.0	0	.	n	.	0	T695C	SNP	695	695	T	1400	1400	C	193	C	119	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3340	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3815	168.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	2042	2042	A	187	A	130	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3340	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3815	168.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2676	2676	C	192	C	123	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3340	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3815	168.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3302	3302	T	178	T,C	105,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3340	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3815	168.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2750	2750	A	184	A	116	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3340	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3815	168.0	0	HET	.	.	.	C1346T	.	1346	1346	C	2051	2051	C	194	C,T	73,59	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	112	folP	855	855	100.0	folP.l15.c4.ctg.1	1135	16.2	1	SNP	p	R229S	1	.	.	685	687	AGC	888	890	AGC	12;12;12	A,T;G;C	6,1;7;6	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	346	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3547	18.9	1	SNP	p	S91F	1	.	.	271	273	TTC	725	727	TTC	30;30;30	T;T;C	19;20;19	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	346	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3547	18.9	1	SNP	p	D95G	1	.	.	283	285	GGC	737	739	GGC	35;36;37	G;G;C	19;21;20	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	346	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3547	18.9	1	SNP	p	G95N	0	.	.	283	285	GGC	737	739	GGC	35;36;37	G;G;C	19;21;20	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	102	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1084	17.2	1	SNP	p	G45D	0	.	.	133	135	GGC	404	406	GGC	34;36;36	G;G;C,G	21;22;22,1	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	54	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	652	14.4	0	.	n	.	0	A197.	DEL	197	197	A	342	342	A	21	A	16	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	304	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2603	21.4	1	SNP	p	D86N	0	.	.	256	258	GAC	371	373	GAC	16;16;17	G;A;C	11;10;10	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	304	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2603	21.4	1	SNP	p	R87I	0	.	.	259	261	CGT	374	376	CGT	17;17;18	C;G;T	11;10;11	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	304	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2603	21.4	1	SNP	p	S87R	1	.	.	259	261	CGT	374	376	CGT	17;17;18	C;G;T	11;10;11	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	304	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2603	21.4	1	SNP	p	R87W	0	.	.	259	261	CGT	374	376	CGT	17;17;18	C;G;T	11;10;11	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	304	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2603	21.4	1	SNP	p	S88P	0	.	.	262	264	TCC	377	379	TCC	18;18;18	T;C;C	12;12;12	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	322	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2804	22.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1524	1526	GGC	22;23;23	G;G;C	16;14;16	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	26.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1401	1403	GCA	35;35;35	G;C;A	21;21;21	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	26.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1404	1406	ATC	35;35;35	A;T;C	22;23;23	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	26.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1416	1418	GTG	32;32;32	G;T;G	19;20;20	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	26.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1416	1418	GTG	32;32;32	G;T;G	19;20;20	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	26.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1920	1922	ACC	18;18;16	A,C;C;C	11,1;13;11	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	26.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1974	1976	GCG	20;18;18	G;C;G	13;8;7	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	26.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1974	1976	GCG	20;18;18	G;C;G	13;8;7	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	26.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2097	2099	AGC	15;15;15	A,C;G;C	10,1;10;10	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	26.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2106	2108	GGC	13;13;13	G;G;C	8;8;8	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	26.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2124	2126	CCG	14;14;14	C;C;G	10;10;10	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	572	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2900	36.0	0	.	p	.	0	V584G	NONSYN	1750	1752	GTT	1888	1890	GGT	30;27;28	G;G,T;T	26;3,1;19	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	572	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2900	36.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1399	1401	CCG	22;21;21	C;C;G	13;13;13	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	182	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1534	22.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	425	425	C	17	C	11	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	182	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1559	22.6	0	.	p	.	0	N38E	NONSYN	112	114	AAT	333	335	GAA	34;34;34	G;A;A	22;22;21	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	182	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1559	22.6	0	.	p	.	0	N134D	NONSYN	400	402	AAT	621	623	GAT	17;19;20	G;A;T	13;15;15	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	182	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1559	22.6	0	.	p	.	0	P175S	NONSYN	523	525	CCA	744	746	TCA	24;24;24	T;C;A	14;16;17	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	182	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1559	22.6	0	.	p	.	0	A218V	NONSYN	652	654	GCC	873	875	GTC	23;21;21	G;T;C	16;14;14	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	182	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1559	22.6	0	.	p	.	0	F222S	NONSYN	664	666	TTT	885	887	TCT	18;18;18	T;C;T	13;12;13	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	182	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1559	22.6	0	.	p	.	0	N260del	DEL	778	778	A	999	999	A	25	A	14	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	182	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1559	22.6	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1200	1202	GCA	22;22;22	G;C;A	18;18;18	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	182	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1559	22.6	1	SNP	p	G120K	1	.	.	358	360	AAG	579	581	AAG	22;22;22	A;A;G	16;15;17	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	182	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1559	22.6	1	SNP	p	A121D	1	.	.	361	363	GAC	582	584	GAC	22;21;20	G;A;C	17;14;11	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	182	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1559	22.6	1	SNP	p	D121N	0	.	.	361	363	GAC	582	584	GAC	22;21;20	G;A;C	17;14;11	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	742	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4980	28.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	76	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1092	13.7	1	SNP	p	V57M	1	.	.	169	171	ATG	450	452	ATG	28;28;28	A;T;G	17;17;18	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
